Skip to main navigation
Focus
Our Focus
Pipeline
Dystrophic EB
Netherton Syndrome
TGM1-deficient ARCI
Cystic Fibrosis
Aesthetic Skin Conditions
Chronic Skin Diseases
Patients and Families
Our gene therapy
Our STAR-D platform
Our Targets
Patient Advocacy
Medical Professionals
About Us
Investors
Contact
Contact Us
Careers
Investors
Investor Relations
Overview
News Releases
Events
Stock Information
SEC Filings
Corporate Governance
Scientific Publications
Email Alerts
Analyst Coverage
Investor FAQs
Third Quarter 2023 Earnings Call
November 6, 2023 at 8:30 AM EST
Click here for webcast
